Article

Combining Pharmacological and Cognitive Behavioral Therapy in the Treatment of Anxiety Disorders

Michael W. Otto, Evelyn Behar, Jasper A. J. Smits and Stefan G. Hofmann

in Oxford Handbook of Anxiety and Related Disorders

Published in print September 2008 | ISBN: 9780195307030
Published online September 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780195307030.013.0032

Series: Oxford Library of Psychology

 Combining Pharmacological and Cognitive Behavioral Therapy in the Treatment of Anxiety Disorders

Show Summary Details

Preview

This chapter is designed to provide an integrated perspective on the issues and efficacy associated with the application of combined cognitive behavioral therapy (CBT) and pharmacotherapy for the anxiety disorders. Important practice characteristics, including the availability, cost, effort, and tolerability of each treatment, are discussed along with a review of efficacy findings. The ongoing hope that combination treatment (CBT plus antidepressants or benzodiazepines) will provide an especially efficacious or cost-effective treatment has not been realized. The chapter closes with consideration of some of the novel and promising combination treatment strategies (e.g., isolated use of D-cycloserine) that, instead of relying on direct treatment of affective disorders, target pharmacotherapy toward the promotion of more optimal learning in CBT.

Keywords: cognitive behavioral therapy; combination treatment; efficacy; nonresponse; pharmacotherapy; treatment tolerability

Article.  8508 words. 

Subjects: Psychology ; Clinical Psychology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.